Organ weights and fat volume in rats as a function of strain and age.
暂无分享,去创建一个
J E Simmons | J. E. Simmons | J. Bruckner | D J Schoeffner | D A Warren | S Muralidara | J V Bruckner | D. J. Schoeffner | D. A. Warren | S. Muralidara | D. Warren
[1] F. Stenbäck,et al. Drug interaction involving changes in liver size and fibrogenesis. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[2] T. Fox,et al. A Comparison of the Fate of Inhaled Methyl Chloroform (1,1,1-Trichloroethane) Following Single or Repeated Exposure in Rats and Mice , 1982 .
[3] L. Birnbaum,et al. Age-related changes in dermal absorption of 2,3,7, 8-tetrachlorodibenzo-p-dioxin and 2,3,4,7,8-pentachlorodibenzofuran. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[4] L. Skovsted,et al. Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in Man , 1981, Clinical pharmacokinetics.
[5] Michael F. W. Festing,et al. Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. , 1996 .
[6] R. S. Yang,et al. Age-dependent pharmacokinetic changes of ethylenediamine in Fischer 344 rats parallel to a two-year chronic toxicity study. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[7] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[8] J E Simmons,et al. Physiologically based pharmacokinetic estimated metabolic constants and hepatotoxicity of carbon tetrachloride after methanol pretreatment in rats. , 1996, Toxicology and applied pharmacology.
[9] H. Wynne,et al. Age-Related Changes in Liver Size and Hepatic Blood Flow , 1988 .
[10] M. E. Lynch,et al. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats. , 1991, Metabolism: clinical and experimental.
[11] D J Paustenbach,et al. Physiologically based pharmacokinetic and pharmacodynamic modeling in health risk assessment and characterization of hazardous substances. , 1995, Toxicology letters.
[12] M. Andersen,et al. Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.
[13] G. Lesser,et al. Aging in the rat: longitudinal and cross-sectional studies of body composition. , 1973, The American journal of physiology.
[14] J E Simmons,et al. Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats. , 1994, Toxicology and applied pharmacology.
[15] L. Birnbaum,et al. Maturational changes in dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in Fischer 344 rats. , 1993, Toxicology and applied pharmacology.
[16] C. Dallas,et al. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics. , 1995, Journal of toxicology and environmental health.
[17] M. Verstegen,et al. Relative growth rates of various fat depot in Sprague Dawley rats. , 1980, Growth.
[18] M E Andersen,et al. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.
[19] L. Birnbaum. Distribution and excretion of 2,3,6,2',3',6'- and 2,4,5,2',4',5'-hexachlorobiphenyl in senescent rats. , 1983, Toxicology and applied pharmacology.